v3.26.1
STATEMENTS OF CHANGES IN SHAREHOLDERS' (DEFICIT) EQUITY - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance – July 23, 2024 at Jul. 22, 2024
Beginning balance, shares at Jul. 22, 2024      
Issuance of Founder Shares to Sponsor [1] $ 290 24,710 25,000
Issuance of Founder Shares to Sponsor, shares 2,898,000      
Net loss (16,018) (16,018)
Balance – March 31, 2025 at Mar. 31, 2025 [2] $ 290 24,710 (16,018) 8,982
Ending balance, shares at Mar. 31, 2025 2,898,000      
Issuance of Private Placement Units $ 23 2,286,477 2,286,500
Issuance of Private Placement Units, shares 228,650      
Issuance of Public Rights net of issuance costs of $102,558 1,801,841 1,801,841
Remeasurement of carrying value to redemption value (6,260,911) (2,046,125) (8,307,036)
Reclassification of negative additional paid-in capital to accumulated deficit 2,147,883 (2,147,883)
Net loss 978,206 978,206
Balance – March 31, 2025 at Mar. 31, 2026 $ 313 $ (3,231,820) $ (3,231,507)
Ending balance, shares at Mar. 31, 2026 3,126,650      
[1] Ordinary shares have been retroactively restated to reflect the first amendment to the Subscription Agreement, which allowed the Sponsor to increase the purchase of ordinary shares from 2,415,000 to 2,898,000 shares for $25,000, including an aggregate of up to 378,000 ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5).
[2] Ordinary shares have been retroactively restated to reflect the first amendment to the Subscription Agreement, which allowed the Sponsor to increase the purchase of ordinary shares from 2,415,000 to 2,898,000 shares for $25,000, including an aggregate of up to 378,000 ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5).